Cerulean Pharma Inc Share Price Nasdaq
Equities
US15708Q1058
Biotechnology & Medical Research
Sales 2024 * | 2.62M 206M | Sales 2025 * | 27.84M 2.18B | Capitalization | 41.05M 3.22B |
---|---|---|---|---|---|
Net income 2024 * | -23M -1.8B | Net income 2025 * | -10M -783M | EV / Sales 2024 * | 15.6 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 1.47 x |
P/E ratio 2024 * |
-1.72
x | P/E ratio 2025 * |
-3.6
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 98.36% |
Latest transcript on Cerulean Pharma Inc
Managers | Title | Age | Since |
---|---|---|---|
Sabrina Johnson
FOU | Founder | 57 | 31/12/14 |
Annie Thurman
CTO | Chief Tech/Sci/R&D Officer | - | 31/12/21 |
Jessica Hatheway
CTO | Chief Tech/Sci/R&D Officer | - | 31/12/21 |
Members of the board | Title | Age | Since |
---|---|---|---|
Robin Steele
BRD | Director/Board Member | 68 | 31/12/14 |
Cheryl Blanchard
BRD | Director/Board Member | 59 | 19/11/19 |
Chairman | 75 | 31/12/13 |
1st Jan change | Capi. | |
---|---|---|
+54.05% | 58.71B | |
-2.02% | 41.31B | |
+37.07% | 39.2B | |
-10.22% | 27.4B | |
+13.42% | 26.55B | |
-21.60% | 18.98B | |
+2.89% | 12.51B | |
+22.40% | 11.94B | |
+27.49% | 12.08B |